KD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kyndryl Holdings Inc (KD) is not a strong buy for a beginner, long-term investor at this moment. While the company has shown some positive developments, such as collaboration with Google Cloud and recognition in mainframe services, the financial performance, analyst sentiment, and technical indicators suggest uncertainty and limited upside potential. The stock should be held for now, and further clarity on financial stability and growth trajectory is needed before considering a buy.
The MACD histogram is positive at 0.177, indicating mild bullish momentum, but it is contracting. RSI_6 is at 41.13, which is neutral and does not indicate overbought or oversold conditions. Moving averages are converging, showing no clear trend direction. Key support is at 12.433, and resistance is at 14.683. The pre-market price of $13.35 is near the pivot point of 13.558, suggesting limited immediate movement.
Kyndryl's collaboration with Google Cloud to enhance IT modernization and sustainability goals is a positive development. The company also won five awards at the 2026 Google Cloud Partner Awards, showcasing its excellence in customer success and innovation. Recognition as a leader in mainframe services highlights its expertise in mission-critical enterprise technology.
Analyst sentiment is largely negative, with multiple downgrades and reduced price targets citing concerns over management changes, delayed filings, and material weaknesses in accounting practices. The abrupt departure of key executives and uncertainty around the company's relationship with IBM add to the risks. Financial performance shows a significant drop in net income (-73.49% YoY) and EPS (-71.91% YoY), despite a slight revenue increase.
In Q3 2026, revenue increased by 3.07% YoY to $3.859 billion. However, net income dropped by 73.49% YoY to $57 million, and EPS fell by 71.91% YoY to $0.25. Gross margin improved by 7.21% YoY to 21.85%. The financials indicate revenue growth but significant profitability challenges.
Analysts have a mixed to negative view on Kyndryl. Recent ratings include downgrades to Neutral, Market Perform, and Underweight, with price targets ranging from $13 to $16. Analysts cite aggressive fiscal targets, management uncertainty, and concerns over accounting practices and contract delivery issues as key risks.
